Free Trial
OTCMKTS:TRUMY

Terumo Q3 2026 Earnings Results & Report

Terumo logo
$15.05 0.00 (0.00%)
As of 11/13/2026 03:55 PM Eastern

Terumo missed analyst earnings expectations but beat on revenue in its Q3 2026 results, released February 13, 2026. The company reported EPS of $0.1450 versus the $0.1453 consensus estimate, while revenue of $1.94 billion topped the $1.82 billion estimate by $122.63 million.

Earnings Announcement Details

Quarter
Q3 2026
Time
Before Market Opens

Terumo EPS Results

Actual EPS
$0.1450
Consensus EPS
$0.1453
Beat/Miss
Missed by -$0.0003
One Year Ago EPS
N/A
EPS Beat Rate
2 of last 8 quarters

Terumo Revenue Results

Actual Revenue
$1.94 billion
Expected Revenue
$1.82 billion
Beat/Miss
Beat by +$122.63 million
YoY Revenue Growth
N/A

Conference Call Resources

Terumo Q3 2026 Earnings FAQ

Terumo (OTCMKTS:TRUMY) reported earnings of $0.1450 per share for Q3 2026, missing the consensus estimate of $0.1453. The report was announced on Friday, February 13, 2026.

Terumo reported revenue of $1.94 billion for Q3 2026, against a consensus estimate of $1.82 billion.

Terumo Earnings Headlines

Terumo (OTCMKTS:TRUMY) Shares Gap Down Following Weak Earnings
$0. Later: $29.97.
Bill Poulos is giving away his Simple Options Trading For Beginners book through a temporary link. Once that link expires, it returns to its usual price of $29.97. The content stays the same - plain-English lessons and a handful of proven techniques - only the price changes. Waiting means paying for something you could have gotten for free.tc pixel
Terumo (OTCMKTS:TRUMY) Stock Falls 7.4% Following Weak Earnings
Terumo Corporation (TRUMY) Q2 2027 Earnings Call Transcript
Terumo ADR (TRUMY) Ratios
See More Terumo Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Terumo? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Terumo and other key companies, straight to your email.

About Terumo

Terumo (OTCMKTS:TRUMY) Corporation is a Japan-based medical technology company that develops and manufactures products for hospitals, clinics and other healthcare providers. Founded in 1921, the company began by producing clinical thermometers and has since expanded into a broad range of medical devices and services.

Terumo’s businesses include cardiovascular and vascular products, such as catheter-based devices and systems used in the treatment of heart and vascular conditions; medical care products, including infusion and injection devices; and blood and cell technologies used to collect, process and manage blood and cellular therapies.

Headquartered in Tokyo, Terumo serves healthcare customers in Japan and markets around the world. Its products support areas including patient care, cardiovascular treatment, transfusion medicine and cell therapy.

View Terumo Profile